Anti-CD154 antibodies are characterized by enhanced consistency, function and safety and are used in human immunotherapy.

摘要

The invention relates generally to a liquid solution formulation including gibberellic acid (“GA₃”), gibberellin₄ (“GA₄”), gibberellin_4/7 (“GA_4/7”), or combinations thereof, and a low-volatile, organic solvent, and methods of their use. Specifically, the liquid solution formulations of the present invention are directed toward agricultural liquid solution formulations including at least one gibberellin and a low-volatile, organic solvent selected from polyethylene glycol, propylene glycol, and/or a non-polymeric glycol.